Episurf Medical First Quarter 2024 Earnings: kr0.077 loss per share (vs kr0.087 loss in 1Q 2023)

Episurf Medical (STO:EPIS B) First Quarter 2024 Results

Key Financial Results

• Revenue: kr3.10m (down 40% from 1Q 2023).
• Net loss: kr20.5m (loss narrowed by 12% from 1Q 2023).
• kr0.077 loss per share (improved from kr0.087 loss in 1Q 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Episurf Medical Earnings Insights

Looking ahead, revenue is forecast to grow 46% p.a. on average during the next 3 years, compared to a 13% growth forecast for the Medical Equipment industry in Sweden.

Performance of the Swedish Medical Equipment industry.

The company's shares are down 44% from a week ago.

Risk Analysis

Be aware that Episurf Medical is showing 5 warning signs in our investment analysis and 3 of those are significant...

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.